Clinical trial
Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin…
NCT00062426 · Prologue Research International, Industry · Completed
Key facts
| NCT number | NCT00062426 |
|---|---|
| Title | Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer |
| Official title | A Randomized, Prospective Study Comparing Three Regimens Of Eloxatin ™ Plus Fluoropyrimidine For Evaluation Of Safety And Tolerability In First Line Treatment Of Patients With Advanced Colorectal Cancer (Tree Study) |
| Lead sponsor | Prologue Research International, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | bevacizumab, capecitabine, fluorouracil, leucovorin calcium, oxaliplatin |
| Start date | May 1, 2003 |
| Completion | Feb 1, 2011 |
| First posted | Jun 6, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: